Salam salamat

Actoverco Pharmaceutical Company

world deaf day

International Day of the Deaf: A Chance to Raise Awareness of the Needs of Deaf Individuals

WORLD DEAF DAY, celebrated on September 30, is dedicated to promoting the rights of the deaf and improving their access to education, employment, and public

World Suicide Prevention Day

Discover the importance of World Suicide Prevention Day, learn about the signs and causes of suicidal thoughts, and explore effective prevention strategies.

World First Aid Day: Raising Awareness

World First Aid Day highlights the critical role that first aid education plays in saving lives. This day serves as a reminder that many individuals

Prostate Cancer Awareness Month: A Path to Raising Men’s Health Awareness

Prostate cancer is one of the most common types of cancer in men, and with proper awareness, the rates of incidence and mortality can be

Alzheimer’s and Brain Awareness Month

Alzheimer's, as the most common form of dementia, causes impairment in memory, thinking, and behavior, gradually reducing an individual's cognitive abilities. This month, there is
Nahale Naraghi honors Pharmacist Day with a special message!

Nahaleh Naraqi honors Pharmacist Day with a special message!

Nahale Naraghi honors Pharmacist Day with a special message of gratitude, recognizing the essential role pharmacists play in advancing healthcare and supporting patient well-being
Nahaleh naraqi

Nahaleh Naraqi’s congratulatory message on the occasion of Doctor’s Day

Nahale Naraghi honors National Doctors Day in Iran, coinciding with Avicenna’s birthday.

Professor Haraton Davidian, the Father of Iranian Psychiatry

In this article, we explore the life of Professor Haraton Davidian and his influence on the field of psychiatry in Iran.

Treatment and Reduction of Menopause Symptoms with New Drugs by “Atipharmed”

The pharmaceutical company "Atipharmed," a subsidiary of the Actover Group, has introduced two new drugs to the national market, which are used for hormone therapy
actonib launch

Visual Report on the Introduction of Actonib and Its application in Dermatology

Baricitinib is the first drug approved by the U.S. Food and Drug Administration (FDA) for the treatment of moderate to severe stages of alopecia areata
actonib launch

Production of the first drug approved by FDA for the treatment of severe alopecia areata in Iran

Baricitinib, marketed under the brand name Actonib, is the first FDA-approved medication for the treatment of moderate to severe alopecia areata in adults.